About ALLYSTA PHARMACEUTICALS, INC.
Allysta Pharmaceuticals is a private, venture-backed clinical-stage biopharmaceutical company focused on developing innovative medicines for rare diseases with high unmet needs, particularly targeting first-in-class therapeutic peptides with multiple biological actions.
Development of first-in-class therapeutic peptides with anti-fibrotic, anti-inflammatory, cell regenerative, and beneficial metabolic effectsExtended release formulation of ALY688 for systemic deliveryExpertise in drug development from lead identification through NDA submissionsExperience in clinical trials across multiple indications, including ophthalmic and rare diseases
Is this your company?
Claim ALLYSTA PHARMACEUTICALS, INC. to unlock the federal & state contracts GovIntel's AI has matched to you right now — plus your own scored past-performance, who you're up against, and who's risky to team with.
Claim ALLYSTA PHARMACEUTICALS, INC. & see your matchesFree to claim. Takes about a minute.
Data compiled from public government sources including SAM.gov, USAspending.gov, and state procurement records. Last verified against federal award records. Inaccurate, or want this page removed? Request a correction or removal.